Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Harvey Robert Klingensmith currently holds 7,895 shares of CORE LABORATORIES N V (CLB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Harvey Robert Klingensmith has been a net neutral trader of CLB stock. They have purchased $0 and sold $0 worth of shares.
Harvey Robert Klingensmith's most recent insider trade was on Apr 1, 2026, when they sold 8,069 shares at $0.00 per share.
Harvey Robert Klingensmith serves as Executive at CORE LABORATORIES N V (CLB). They have executed 10 insider transactions totaling $0 over their tenure at the company.
Harvey Robert Klingensmith holds the position of Executive at CORE LABORATORIES N V, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Harvey Robert Klingensmith has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Harvey Robert Klingensmith was on Apr 1, 2021, when they sold $2.2K worth of CLB shares. This transaction involved 73 shares at $30.10 per share.
Harvey Robert Klingensmith currently owns 7,895 shares of CORE LABORATORIES N V (CLB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Harvey Robert Klingensmith's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Harvey Robert Klingensmith has 10 Form 4 filings on record as an insider at CORE LABORATORIES N V.
Set alerts for Harvey Robert Klingensmith and 40,000+ other insiders.